Connor, Clark & Lunn Investment Management (CC&L)’s Adicet Bio ACET Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-51,175
| Closed | -$49.2K | – | 1385 |
|
|
2024
Q4 | $49.2K | Sell |
51,175
-129,618
| -72% | -$125K | ﹤0.01% | 1373 |
|
|
2024
Q3 | $260K | Sell |
180,793
-32,030
| -15% | -$46.1K | ﹤0.01% | 1277 |
|
|
2024
Q2 | $258K | Sell |
212,823
-203,471
| -49% | -$246K | ﹤0.01% | 1218 |
|
|
2024
Q1 | $978K | Buy |
+416,294
| New | +$978K | ﹤0.01% | 897 |
|
|
2022
Q4 | – | Sell |
-124,379
| Closed | -$1.77M | – | 1180 |
|
|
2022
Q3 | $1.77M | Buy |
124,379
+89,088
| +252% | +$1.27M | 0.01% | 518 |
|
|
2022
Q2 | $515K | Buy |
35,291
+349
| +1% | +$5.09K | ﹤0.01% | 766 |
|
|
2022
Q1 | $698K | Buy |
34,942
+7,702
| +28% | +$154K | ﹤0.01% | 726 |
|
|
2021
Q4 | $476K | Buy |
+27,240
| New | +$476K | ﹤0.01% | 807 |
|